Kim Lyerly

Core Faculty

Kim Lyerly, MD

Contact

lyerl001@mc.duke.edu

Degree

MD, University of California at Los Angeles

From Scholars@Duke

Scholars@Duke Profile

Hafez N, Rugo HS, Tempero MA, Fox E, Reaman GH, Lyerly HK, et al. Novel Therapeutic Interventions Early in the Disease Trajectory: Drug Development Beyond the Refractory Setting. Clin Cancer Res. 2020 Sep 15;26(18):4743–7.

Crosby EJ, Acharya CR, Haddad A-F, Rabiola CA, Lei G, Wei J-P, et al. Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer. Clin Cancer Res. 2020 Sep 1;26(17):4670–81.

Trotter TN, Shuptrine CW, Tsao L-C, Marek RD, Acharya C, Wei J-P, et al. IL26, a Noncanonical Mediator of DNA Inflammatory Stimulation, Promotes TNBC Engraftment and Progression in Association with Neutrophils. Cancer Res. 2020 Aug 1;80(15):3088–100.